Home » Topics » Regulatory

Regulatory
RSS

FDA approves Remeron SolTab for treatment of depression

Jan. 17, 2001

UCB's nonsedating antihistamine approved in Germany

Jan. 16, 2001

Nutropin Depot development expanded by Genentech and Alkermes

Jan. 15, 2001

Preclinical studies further define effects underlying tranilast's efficacy in preventing restenosis

Jan. 15, 2001

Provalis obtains U.K. marketing rights to Pennsaid topical solution

Jan. 12, 2001

FDA approves Femara for first-line treatment of breast cancer

Jan. 11, 2001

Expanded phase III trial program in bipolar disorder announced for Seroquel

Jan. 10, 2001

Argatroban sNDA filed for HIT patients undergoing PCI

Jan. 10, 2001

IND submitted for salmon calcitonin as oral osteoporosis treatment

Jan. 9, 2001

Marketing agreement with Bioglan for Solaraze expanded by SkyePharma

Jan. 8, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...